These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.
    Author: Gibson TS, Johnson B, Fanjul A, Halkowycz P, Dougan DR, Cole D, Swann S.
    Journal: Bioorg Med Chem Lett; 2017 Apr 15; 27(8):1709-1713. PubMed ID: 28291695.
    Abstract:
    Structure-based drug design is an iterative process that is an established means to accelerate lead optimization, and is most powerful when integrated with information from different sources. Herein is described the use of such methods in conjunction with deconstruction and re-optimization of a diverse series of ASK1 chemotypes along with high-throughput screening that lead to the identification of a novel series of efficient ASK1 inhibitors displaying robust MAP3K pathway inhibition.
    [Abstract] [Full Text] [Related] [New Search]